Viewing Study NCT06253195

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:33 PM
Ignite Modification Date: 2026-02-05 @ 3:22 AM
Study NCT ID: NCT06253195
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-05
First Post: 2024-02-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Sponsor: BeiGene
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumor View
None Metastatic Solid Tumor View
None Hormone-receptor-positive Breast Cancer View
None Breast Cancer View
None Metastatic Breast Cancer View
None Hormone Receptor Positive Malignant Neoplasm of Breast View
None HER2-negative Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None advanced solid tumor View
None metastatic solid tumor View
None BGB-43395 View
None breast cancer View
None HR+/HER2- breast cancer View
None hormone receptor positive breast cancer View